Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease

The provided document contains only administrative information about the comment and notice periods and a title revision for the MolDX LCD concerning the Decipher/Prostate Cancer Genomic Classifier assay; it does not include any clinical coverage criteria, exclusions, required documentation, or frequency limits. Manual review of the referenced LCD (L38292) or the full policy text is required to extract actionable indications, limitations, documentation requirements, and frequency limits.

"Provided text contains only administrative metadata (comment period dates, notice period, effective date, and LCD title revision) and does not include coverage indications, limitations, documentati..."

Sign up to see full coverage criteria, indications, and limitations.